<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Thomas CE</submitter><funding>Intramural NIH HHS</funding><funding>Austrian Research Funding Agency</funding><funding>World Health Organization</funding><funding>NIA NIH HHS</funding><funding>German Research Council</funding><funding>Junta de Castilla y León</funding><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><funding>International Agency for Research on Cancer</funding><funding>Spanish Association Against Cancer</funding><funding>German Federal Ministry of Education and Research</funding><funding>Herzfelder&amp;apos;sche Familienstiftung</funding><funding>American Cancer Society</funding><funding>Instituto de Salud Carlos III</funding><funding>NIDDK NIH HHS</funding><funding>Victorian Cancer Agency</funding><funding>NHGRI NIH HHS</funding><funding>NCI NIH HHS</funding><funding>Australian NHMRC</funding><funding>NIH HHS</funding><funding>WHI NIH HHS</funding><pagination>534-546</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10990777</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>33(4)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The genotoxin colibactin causes a tumor single-base substitution (SBS) mutational signature, SBS88. It is unknown whether epidemiologic factors' association with colorectal cancer risk and survival differs by SBS88.&lt;h4>Methods&lt;/h4>Within the Genetic Epidemiology of Colorectal Cancer Consortium and Colon Cancer Family Registry, we measured SBS88 in 4,308 microsatellite stable/microsatellite instability low tumors. Associations of epidemiologic factors with colorectal cancer risk by SBS88 were assessed using multinomial regression (N = 4,308 cases, 14,192 controls; cohort-only cases N = 1,911), and with colorectal cancer-specific survival using Cox proportional hazards regression (N = 3,465 cases).&lt;h4>Results&lt;/h4>392 (9%) tumors were SBS88 positive. Among all cases, the hi</pubmed_abstract><journal>Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</journal><pubmed_title>Epidemiologic Factors in Relation to Colorectal Cancer Risk and Survival by Genotoxic Colibactin Mutational Signature.</pubmed_title><pmcid>PMC10990777</pmcid><funding_grant_id>U01 CA137088</funding_grant_id><funding_grant_id>K01 DK120742</funding_grant_id><funding_grant_id>Z01 CP 010200</funding_grant_id><funding_grant_id>R01 CA488857</funding_grant_id><funding_grant_id>CA107333</funding_grant_id><funding_grant_id>P01 CA087969</funding_grant_id><funding_grant_id>U01 CA176726</funding_grant_id><funding_grant_id>CH 117/1-1</funding_grant_id><funding_grant_id>HHSN261201000032C</funding_grant_id><funding_grant_id>U01CA261961</funding_grant_id><funding_grant_id>U01 CA261961</funding_grant_id><funding_grant_id>R21 CA191312</funding_grant_id><funding_grant_id>PI09-1286</funding_grant_id><funding_grant_id>509348</funding_grant_id><funding_grant_id>R01 CA151993</funding_grant_id><funding_grant_id>R35 CA253185</funding_grant_id><funding_grant_id>HHSN268201100001I</funding_grant_id><funding_grant_id>LE22A10-2</funding_grant_id><funding_grant_id>R01 CA244588</funding_grant_id><funding_grant_id>HHSN268201100001C</funding_grant_id><funding_grant_id>KL 2354/3-1</funding_grant_id><funding_grant_id>U01 HG004438</funding_grant_id><funding_grant_id>R01 CA137178</funding_grant_id><funding_grant_id>209057</funding_grant_id><funding_grant_id>MCRF18005</funding_grant_id><funding_grant_id>K01DK120742</funding_grant_id><funding_grant_id>HE 5998/2-1</funding_grant_id><funding_grant_id>001</funding_grant_id><funding_grant_id>BR 1704/6-3</funding_grant_id><funding_grant_id>BR 1704/6-1</funding_grant_id><funding_grant_id>S10OD028685</funding_grant_id><funding_grant_id>P30 CA015083</funding_grant_id><funding_grant_id>01ER0815</funding_grant_id><funding_grant_id>HHSN268201100002I</funding_grant_id><funding_grant_id>01ER0814</funding_grant_id><funding_grant_id>BR 1704/6-4</funding_grant_id><funding_grant_id>HHSN268201100002C</funding_grant_id><funding_grant_id>HHSN268201100046C</funding_grant_id><funding_grant_id>01ER1505B</funding_grant_id><funding_grant_id>01ER1505A</funding_grant_id><funding_grant_id>UM1 CA186107</funding_grant_id><funding_grant_id>R01 CA206279</funding_grant_id><funding_grant_id>R01 CA107333</funding_grant_id><funding_grant_id>R35 CA197735</funding_grant_id><funding_grant_id>U01 HG004446</funding_grant_id><funding_grant_id>U01 CA167552</funding_grant_id><funding_grant_id>U01 CA167551</funding_grant_id><funding_grant_id>GCTRA18022MORE</funding_grant_id><funding_grant_id>NIH U01 HG004446</funding_grant_id><funding_grant_id>T32 CA009168</funding_grant_id><funding_grant_id>Z01 CP010200</funding_grant_id><funding_grant_id>HHSN268201100003C</funding_grant_id><funding_grant_id>HHSN268201700006C</funding_grant_id><funding_grant_id>251553</funding_grant_id><funding_grant_id>UM1 CA167552</funding_grant_id><funding_grant_id>504711</funding_grant_id><funding_grant_id>COST Action BM1206</funding_grant_id><funding_grant_id>R37 CA246175</funding_grant_id><funding_grant_id>HHSN268201200008I</funding_grant_id><funding_grant_id>S10 OD028685</funding_grant_id><funding_grant_id>P01 CA055075</funding_grant_id><funding_grant_id>HHSN268201100003I</funding_grant_id><funding_grant_id>R01 CA059045</funding_grant_id><funding_grant_id>829675</funding_grant_id><funding_grant_id>HHSN268201200008C</funding_grant_id><funding_grant_id>P20 CA252733</funding_grant_id><funding_grant_id>U01 CA164930</funding_grant_id><funding_grant_id>R01 CA215151</funding_grant_id><funding_grant_id>R01 CA201407</funding_grant_id><funding_grant_id>P30 CA015704</funding_grant_id><funding_grant_id>RO 2270/8-1</funding_grant_id><funding_grant_id>L70 CA284301</funding_grant_id><funding_grant_id>R37CA246175</funding_grant_id><funding_grant_id>HHSN268201100004C</funding_grant_id><funding_grant_id>PI14-613</funding_grant_id><funding_grant_id>R01 CA068535</funding_grant_id><funding_grant_id>01KH0404</funding_grant_id><funding_grant_id>HO 5117/2-1</funding_grant_id><funding_grant_id>T32 CA094880</funding_grant_id><funding_grant_id>HHSN271201100004C</funding_grant_id><funding_grant_id>HHSN268201100004I</funding_grant_id><funding_grant_id>GEI U01 HG 004438</funding_grant_id><pubmed_authors>Qu C</pubmed_authors><pubmed_authors>Um CY</pubmed_authors><pubmed_authors>Huang WY</pubmed_authors><pubmed_authors>Toland AE</pubmed_authors><pubmed_authors>Trinh QM</pubmed_authors><pubmed_authors>Berndt SI</pubmed_authors><pubmed_authors>Zaidi SH</pubmed_authors><pubmed_authors>Drew DA</pubmed_authors><pubmed_authors>Phipps AI</pubmed_authors><pubmed_authors>Thomas CE</pubmed_authors><pubmed_authors>Murphy N</pubmed_authors><pubmed_authors>Song M</pubmed_authors><pubmed_authors>Huyghe JR</pubmed_authors><pubmed_authors>Peters U</pubmed_authors><pubmed_authors>Gunter MJ</pubmed_authors><pubmed_authors>Buchanan DD</pubmed_authors><pubmed_authors>Newcomb PA</pubmed_authors><pubmed_authors>Melaku YA</pubmed_authors><pubmed_authors>Chan AT</pubmed_authors><pubmed_authors>Obon-Santacana M</pubmed_authors><pubmed_authors>Giannakis M</pubmed_authors><pubmed_authors>Lynch BM</pubmed_authors><pubmed_authors>French AJ</pubmed_authors><pubmed_authors>Steinfelder RS</pubmed_authors><pubmed_authors>Sun W</pubmed_authors><pubmed_authors>Ugai T</pubmed_authors><pubmed_authors>Van Guelpen B</pubmed_authors><pubmed_authors>Ogino S</pubmed_authors><pubmed_authors>Figueiredo JC</pubmed_authors><pubmed_authors>Gruber SB</pubmed_authors><pubmed_authors>Harrison TA</pubmed_authors><pubmed_authors>Campbell PT</pubmed_authors><pubmed_authors>Moreno V</pubmed_authors><pubmed_authors>Hullar MA</pubmed_authors><pubmed_authors>Cao Y</pubmed_authors><pubmed_authors>Jenkins MA</pubmed_authors><pubmed_authors>Gsur A</pubmed_authors><pubmed_authors>Hsu L</pubmed_authors><pubmed_authors>Boardman LA</pubmed_authors><pubmed_authors>Newton CC</pubmed_authors><pubmed_authors>Aglago EK</pubmed_authors><pubmed_authors>Georgeson P</pubmed_authors><pubmed_authors>Goode EL</pubmed_authors><pubmed_authors>Hoffmeister M</pubmed_authors><pubmed_authors>Nowak JA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epidemiologic Factors in Relation to Colorectal Cancer Risk and Survival by Genotoxic Colibactin Mutational Signature.</name><description>&lt;h4>Background&lt;/h4>The genotoxin colibactin causes a tumor single-base substitution (SBS) mutational signature, SBS88. It is unknown whether epidemiologic factors' association with colorectal cancer risk and survival differs by SBS88.&lt;h4>Methods&lt;/h4>Within the Genetic Epidemiology of Colorectal Cancer Consortium and Colon Cancer Family Registry, we measured SBS88 in 4,308 microsatellite stable/microsatellite instability low tumors. Associations of epidemiologic factors with colorectal cancer risk by SBS88 were assessed using multinomial regression (N = 4,308 cases, 14,192 controls; cohort-only cases N = 1,911), and with colorectal cancer-specific survival using Cox proportional hazards regression (N = 3,465 cases).&lt;h4>Results&lt;/h4>392 (9%) tumors were SBS88 positive. Among all cases, the hi</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2025-04-04T01:03:19.633Z</modification><creation>2025-04-04T01:03:19.633Z</creation></dates><accession>S-EPMC10990777</accession><cross_references><pubmed>38252034</pubmed><doi>10.1158/1055-9965.EPI-23-0600</doi><doi>10.1158/1055-9965.epi-23-0600</doi></cross_references></HashMap>